Fischer Medical Ventures Quarterly Results for Trading Insights
In Mar 2026, Fischer Medical Ventures (FISCHER) reported revenue ₹98 Cr and net profit ₹-12 Cr — revenue +100.0% YoY. Analyse FISCHER promoter holding to track promoter, FII and institutional holdings.
FISCHER Quarterly Results — Revenue, Profit & EPS Highlights
Fischer Medical Ventures latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit Fischer Medical Ventures share price chart.
- Revenue of ₹98 Cr in Mar 2026 (+18.1% vs Jun 2026, +100.0% vs Mar 2025)
- Net Profit of ₹-12 Cr in Mar 2026 (-400.0% vs Jun 2026, -1300.0% vs Mar 2025)
- EBITDA of ₹-3 Cr in Mar 2026 (-123.1% vs Jun 2026)
- Operating Margin of -4.0% in Mar 2026 (-18.0pp vs Jun 2026)
- Earnings Per Share of ₹-0.19 in Mar 2026 (-416.7% vs Jun 2026)
Fischer Medical Ventures Quarterly Results — Revenue, EBITDA, Net Profit & EPS
FISCHER quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Mar 2026 | Jun 2026 | Sept 2025 | Mar 2025 | Jun 2025 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 98 | 83 | 89 | 49 | 31 | 18.1% | 100.0% |
| Net Profit (₹ Cr) | -12 | 4 | 14 | 1 | 5 | - | - |
| EBITDA (₹ Cr) | -3 | 13 | 19 | 3 | 12 | - | - |
| EPS (₹) | -0.19 | 0.06 | 0.22 | -0.05 | 0.08 | - | - |
| Operating Margin (%) | -4.0% | 14.0% | 19.0% | 5.0% | 17.0% | - | - |
FISCHER Share Price Trend — 1-Year Movement Across Quarterly Results
Fischer Medical Ventures 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. View FISCHER annual price range for the annual high/low range and current price position.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
FISCHER vs Chemicals Peers — Quarterly Revenue, Profit & Market Cap
Fischer Medical Ventures latest quarter revenue and net profit vs Chemicals competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Pidilite Industries
Mar 2026 |
₹157,124.16 Cr | 1572.1 | 3,648 | 584 | -21.7% | - | 16.0% | 276.3 |
|
SRF
Mar 2026 |
₹73,516.32 Cr | 2512.0 | 4,557 | 582 | -8.4% | - | 12.8% | 128.0 |
|
Coromandel Internat…
Mar 2026 |
₹57,167.94 Cr | 1999.5 | 6,068 | 115 | -26.1% | - | 1.9% | 420.9 |
|
Linde
Mar 2026 |
₹53,110.75 Cr | 6241.5 | 621 | 77 | -11.5% | - | 12.4% | 687.4 |
|
Gujarat Fluorochemi…
Mar 2026 |
₹50,545.28 Cr | 4586.7 | 1,375 | 100 | -14.1% | - | 7.3% | 462.4 |
All amounts in ₹ Crores